Clinical trial
Efficacy of Diazoxide in Type 1 Diabetes
NCT00131755 · Grill, Valdemar, M.D., Other · Completed
Key facts
| NCT number | NCT00131755 |
|---|---|
| Title | Efficacy of Diazoxide in Type 1 Diabetes |
| Official title | Efficacy of 6 Months Treatment With Diazoxide at Bedtime in Preventing Beta-cell Demise in Newly Diagnosed Type 1 Diabetes |
| Lead sponsor | Grill, Valdemar, M.D., Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | diazoxide |
| Enrollment | 40 |
| Start date | Feb 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Aug 19, 2005 |
| Last update posted | Jul 18, 2011 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: